Deciphera Pharmaceuticals
Deciphera Pharmaceuticals, a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for cancer and other serious diseases. Founded in 2003, the company has made significant strides in the oncology sector, particularly with its proprietary drug discovery platform that targets specific molecular pathways.
With a strong presence in the US and expanding operations globally, Deciphera is renowned for its core product, ripretinib, which offers a unique approach to treating gastrointestinal stromal tumours (GIST). The company’s commitment to advancing precision medicine has positioned it as a notable player in the industry, achieving key milestones such as successful clinical trials and regulatory approvals. Deciphera Pharmaceuticals continues to drive innovation, aiming to improve patient outcomes through its cutting-edge therapies.
+21 vs industry average
Deciphera Pharmaceuticals’s score of 59 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Deciphera Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Deciphera Pharmaceuticals yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Deciphera Pharmaceuticals’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Deciphera Pharmaceuticals yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Ono Pharmaceutical Co., Ltd.
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Ono Pharmaceutical Co., Ltd.RE 100
Inherited from Ono Pharmaceutical Co., Ltd.Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project